Premium
Is high‐dose intensity intraarterial cisplatin chemoradiotherapy for head and neck carcinoma feasible?
Author(s) -
Robbins K. Thomas
Publication year - 2005
Publication title -
cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.052
H-Index - 304
eISSN - 1097-0142
pISSN - 0008-543X
DOI - 10.1002/cncr.20807
Subject(s) - medicine , cisplatin , concomitant , chemoradiotherapy , head and neck , radiation therapy , head and neck cancer , carcinoma , chemotherapy , oncology , surgery , nuclear medicine
The author outlines his personal experience treating hundreds of patients with head and neck carcinoma using combined high‐dose intraarterial cisplatin chemotherapy and concomitant, radiation therapy, and he also highlights the published experience of other investigators, all of whom concluded that the high‐dose intensity approach is feasible and highly efficacious. This differs from the results reported in this issue by a group of investigators from the Mayo Clinic. See referenced original article on pages 559–68, this issue.